People over 50 years of age in Britain will be offered a third dose of the coronavirus vaccine in the fall of 2021, which will reduce the spread of the disease by Christmas. This was reported Wednesday, May 5, by the British newspaper The Times.
Two vaccine options are currently being tested under the direction of the country’s chief medical officer of health, Chris Whitty. So, the first option involves the use of preparations from the coronavirus, which have been modified specifically to combat new strains of the virus.
As an alternative to this scenario, vaccination with one of three drugs approved in Britain: Pfizer/BioNTech, Moderna and AstraZeneca.
Earlier, on April 22, the Medicines and Healthcare Products Agency of the United Kingdom reported that the number of people who had developed thrombosis as a result of vaccination with the coronavirus drug produced by the British-Swedish company AstraZeneca increased to 168 people. It is specified that 32 people died because of the specified side effects, but the British regulator called for continued vaccination of the population with the relevant drug.